D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 57 Citations 11,554 288 World Ranking 9375 National Ranking 691

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • Internal medicine

His primary areas of study are Cell biology, Cathelicidin, Innate immune system, Antimicrobial peptides and Microbiology. His Cell biology research is multidisciplinary, relying on both Mast cell, Inflammation, Proinflammatory cytokine and Bone marrow. His Cathelicidin study combines topics in areas such as Rectum, Adverse effect and Saline.

His study looks at the intersection of Innate immune system and topics like MAPK/ERK pathway with Reactive oxygen species. Isao Nagaoka interconnects Chemokine, Secretion and Cytokine in the investigation of issues within Antimicrobial peptides. His studies deal with areas such as Antibacterial activity, Escherichia coli and Staphylococcus aureus as well as Microbiology.

His most cited work include:

  • Antimicrobial Peptides Human β-Defensins Stimulate Epidermal Keratinocyte Migration, Proliferation and Production of Proinflammatory Cytokines and Chemokines (383 citations)
  • A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. (339 citations)
  • Evaluation of the effects of peptide antibiotics human β-defensins-1/-2 and LL-37 on histamine release and prostaglandin D2 production from mast cells (296 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Internal medicine, Biochemistry, Molecular biology, Cell biology and Endocrinology. His research investigates the link between Molecular biology and topics such as Messenger RNA that cross with problems in Growth factor and Platelet-derived growth factor receptor. His work carried out in the field of Cell biology brings together such families of science as Inflammation, Apoptosis, Cathelicidin, Antimicrobial peptides and Degranulation.

The concepts of his Inflammation study are interwoven with issues in Chemotaxis and Pharmacology. In his research on the topic of Cathelicidin, Sepsis is strongly related with Lipopolysaccharide. His work focuses on many connections between Antimicrobial peptides and other disciplines, such as Innate immune system, that overlap with his field of interest in Microbiology.

He most often published in these fields:

  • Internal medicine (29.11%)
  • Biochemistry (20.89%)
  • Molecular biology (19.18%)

What were the highlights of his more recent work (between 2013-2021)?

  • Internal medicine (29.11%)
  • Endocrinology (15.07%)
  • Sepsis (6.51%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Endocrinology, Sepsis, Immunology and Glucosamine. In general Internal medicine study, his work on Adverse effect, Type II collagen and Chemotherapy often relates to the realm of Cartilage metabolism, thereby connecting several areas of interest. His studies in Sepsis integrate themes in fields like Antithrombin, Lipopolysaccharide, Microbiology, Microcirculation and Peptide.

His Glucosamine research incorporates elements of Synovial Cell, Athletes, Pharmacology and Cell biology. He combines subjects such as Inflammation and Phosphorylation with his study of Synovial Cell. Isao Nagaoka does research in Cell biology, focusing on Extracellular specifically.

Between 2013 and 2021, his most popular works were:

  • Antimicrobial cathelicidin peptide LL-37 inhibits the LPS/ATP-induced pyroptosis of macrophages by dual mechanism. (68 citations)
  • Bone Marrow Adipocytes Facilitate Fatty Acid Oxidation Activating AMPK and a Transcriptional Network Supporting Survival of Acute Monocytic Leukemia Cells. (65 citations)
  • Heparins attenuated histone-mediated cytotoxicity in vitro and improved the survival in a rat model of histone-induced organ dysfunction (43 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • Internal medicine

Isao Nagaoka spends much of his time researching Immunology, Internal medicine, Lipopolysaccharide, Pharmacology and Endocrinology. His research integrates issues of Osteocalcin and Oncology in his study of Internal medicine. His Lipopolysaccharide study also includes fields such as

  • Programmed cell death that connect with fields like Proteases, Recombinant DNA, Annexin and Neutrophil extracellular traps,
  • Cytokine, which have a strong connection to Chemokine, Tumor necrosis factor alpha, Antimicrobial peptides and Caspase 1.

Isao Nagaoka has researched Proteases in several fields, including Inflammation and Cell biology. His biological study spans a wide range of topics, including Histone H3, Functional food, Glucosamine and MAPK/ERK pathway. His work in Endocrinology tackles topics such as Type II collagen which are related to areas like Anterior cruciate ligament and Matrix metalloproteinase.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Antimicrobial Peptides Human β-Defensins Stimulate Epidermal Keratinocyte Migration, Proliferation and Production of Proinflammatory Cytokines and Chemokines

François Niyonsaba;Hiroko Ushio;Nobuhiro Nakano;William Ng.
Journal of Investigative Dermatology (2007)

642 Citations

A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis.

François Niyonsaba;Kazuhisa Iwabuchi;Akimasa Someya;Michimasa Hirata.
Immunology (2002)

541 Citations

Evaluation of the effects of peptide antibiotics human β-defensins-1/-2 and LL-37 on histamine release and prostaglandin D2 production from mast cells

François Niyonsaba;Akimasa Someya;Michimasa Hirata;Hideoki Ogawa.
European Journal of Immunology (2001)

472 Citations

mRNA Expression of Growth Factors in Glomeruli From Diabetic Rats

Tsukasa Nakamura;Mitsumine Fukui;Isao Ebihara;Shiori Osada.
Diabetes (1993)

421 Citations

Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells.

Isao Nagaoka;Satoko Hirota;François Niyonsaba;Michimasa Hirata.
Journal of Immunology (2001)

343 Citations

Human β‐defensin‐2 functions as a chemotactic agent for tumour necrosis factor‐α‐treated human neutrophils

François Niyonsaba;Hideoki Ogawa;Isao Nagaoka.
Immunology (2004)

335 Citations

An Antimicrobial Cathelicidin Peptide, Human CAP18/LL-37, Suppresses Neutrophil Apoptosis via the Activation of Formyl-Peptide Receptor-Like 1 and P2X7

Isao Nagaoka;Hiroshi Tamura;Michimasa Hirata.
Journal of Immunology (2006)

330 Citations

Epithelial cell-derived human β-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway

François Niyonsaba;Kazuhisa Iwabuchi;Hiroshi Matsuda;Hideoki Ogawa.
International Immunology (2002)

313 Citations

The human β-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes

François Niyonsaba;Hiroko Ushio;Isao Nagaoka;Ko Okumura.
Journal of Immunology (2005)

307 Citations

Antimicrobial Peptides Human β-Defensins and Cathelicidin LL-37 Induce the Secretion of a Pruritogenic Cytokine IL-31 by Human Mast Cells

François Niyonsaba;Hiroko Ushio;Mutsuko Hara;Hidenori Yokoi.
Journal of Immunology (2010)

281 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Isao Nagaoka

Robert E. W. Hancock

Robert E. W. Hancock

University of British Columbia

Publications: 72

Richard L. Gallo

Richard L. Gallo

University of California, San Diego

Publications: 51

Hideoki Ogawa

Hideoki Ogawa

Juntendo University

Publications: 41

Marina Konopleva

Marina Konopleva

The University of Texas MD Anderson Cancer Center

Publications: 30

Donald J. Davidson

Donald J. Davidson

University of Edinburgh

Publications: 29

Pieter S. Hiemstra

Pieter S. Hiemstra

Leiden University Medical Center

Publications: 26

Michael Andreeff

Michael Andreeff

The University of Texas MD Anderson Cancer Center

Publications: 25

Ko Okumura

Ko Okumura

Juntendo University

Publications: 24

Toshihide Kobayashi

Toshihide Kobayashi

University of Strasbourg

Publications: 24

Octavio L. Franco

Octavio L. Franco

Universidade Católica de Brasília

Publications: 19

Fuad N. Ziyadeh

Fuad N. Ziyadeh

American University of Beirut

Publications: 18

Alessandro Prinetti

Alessandro Prinetti

University of Milan

Publications: 17

Dawn M. E. Bowdish

Dawn M. E. Bowdish

McMaster University

Publications: 17

Jürgen Harder

Jürgen Harder

Kiel University

Publications: 17

Artur Schmidtchen

Artur Schmidtchen

Lund University

Publications: 16

Henk P. Haagsman

Henk P. Haagsman

Utrecht University

Publications: 16

Trending Scientists

Kenji Suzuki

Kenji Suzuki

Tokyo Institute of Technology

Dan Xiao

Dan Xiao

Sichuan University

M. J. Graham

M. J. Graham

National Research Council Canada

Yinhua Zhou

Yinhua Zhou

Huazhong University of Science and Technology

Prashant N. Kumta

Prashant N. Kumta

University of Pittsburgh

Bruno Streit

Bruno Streit

Goethe University Frankfurt

Bruno Fady

Bruno Fady

INRAE : Institut national de recherche pour l'agriculture, l'alimentation et l'environnement

Tzvi Tzfira

Tzvi Tzfira

University of Michigan–Ann Arbor

Asim K. Bej

Asim K. Bej

University of Alabama at Birmingham

Nadja Schröder

Nadja Schröder

Federal University of Rio Grande do Sul

Adriana Galván

Adriana Galván

University of California, Los Angeles

Eugene O. Major

Eugene O. Major

National Institutes of Health

Masaki Yasukawa

Masaki Yasukawa

Ehime University

Molly J. Crockett

Molly J. Crockett

Yale University

Alan Kim Johnson

Alan Kim Johnson

University of Iowa

R. P. Lin

R. P. Lin

University of California, Berkeley

Something went wrong. Please try again later.